Evidence map›Paper›PMID 26525294›Full record

ArticleBMC nephrology2015

Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection.

Jian Shi, Fengbao Luo, Qianqian Shi, Xianlin Xu, Xiaozhou He, Ying Xia

Open access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in BMC nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Extracellular Vesicles from Immune Cells: A Biomedical Perspective.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor-specific antibody formation after transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  14. Review
  15. CXCR5Frontiers in immunology · 2019
    Article
  16. Review
  17. Article
  18. Increased levels of CCR7(lo)PD-1(hi) CXCR5Experimental and therapeutic medicine · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jian ShiThird Clinical College of Soochow University, Changzhou, Jiangsu, China. shijian201205@163.com.
Fengbao LuoThird Clinical College of Soochow University, Changzhou, Jiangsu, China. luofengbao@sohu.com.
Qianqian ShiThird Clinical College of Soochow University, Changzhou, Jiangsu, China. dyqianqian@126.com.
Xianlin XuThird Clinical College of Soochow University, Changzhou, Jiangsu, China. xianlinxu@126.com.
Xiaozhou HeThird Clinical College of Soochow University, Changzhou, Jiangsu, China. czyyhxz@sina.cn.
Ying XiaThe University of Texas Medical School at Houston, Houston, TX, USA. Ying.Xia@uth.tmc.edu.
Soochow University · CN

Funding

A new strategy for protection from cerebral ischemiaR01AT004422 · NCCIH · YALE UNIVERSITY · PI XIA, YING · 2009 to 2013
$1.9M
NCCIH NIH HHS AT-004422NCCIH NIH HHS R01 AT004422
6 · The paper itself

Abstract

backgroundChronic antibody-mediated rejection is a major issue that affects long-term renal allograft survival. Since follicular helper T (Tfh) cells promote the development of antigen-specific B cells in alloimmune responses, we investigated the potential roles of Tfh cells, B cells and their alloimmune-regulating molecules in the pathogenesis of chronic renal allograft rejection in this study.

methodsThe frequency of Tfh, B cells and the levels of their alloimmune-regulating molecules including chemokine receptor type 5 (CXCR5), inducible T cell co-stimulator (ICOS), programmed death-1 (PD-1), ICOSL, PDL-1 and interleukin-21 (IL-21), of peripheral blood were comparatively measured in 42 primary renal allograft recipients within 1-3 years after transplantation. Among them, 24 patients had definite chronic rejection, while other 18 patients had normal renal function.

resultsTfh-cell ratio was significantly increased with PD-1 down-regulation in the patients with chronic renal allograft rejection, while B cells and the alloimmune-regulating molecules studied did not show any appreciable change in parallel.

conclusionsThe patients with chronic renal allograft rejection have a characteristic increase in circulating Tfh cells with a decrease in PD-1 expression. These pathological changes may be a therapeutic target for the treatment of chronic renal allograft rejection and can be useful as a clinical index for monitoring conditions of renal transplant.

Indexed as

AdultAllograftsB-LymphocytesChronic DiseaseFemaleGraft RejectionHumansKidney TransplantationMaleMiddle AgedProgrammed Cell Death 1 ReceptorT-Lymphocytes, Helper-InducerTreatment OutcomePDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID26525294
PMCPMC4630917
OpenAlexW2151852575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.